Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer

BACKGROUND: Previous studies indicate the benefit of therapy depends on patients’ risk for cancer recurrence relative to non-cancer mortality (ω ratio). We sought to test the hypothesis that head and neck cancer (HNC) patients with a higher ω ratio selectively benefit from intensive therapy. METHODS...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Mell, Loren K., Shen, Hanjie, Nguyen-Tân, Phuc Felix, Rosenthal, David I., Zakeri, Kaveh, Vitzthum, Lucas K., Frank, Steven J., Schiff, Peter B., Trotti, Andrea M., Bonner, James A., Jones, Christopher U., Yom, Sue S., Thorstad, Wade L., Wong, Stuart J., Shenouda, George, Ridge, John A., Zhang, Qiang E., Le, Quynh-Tu
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028339/
https://ncbi.nlm.nih.gov/pubmed/31420360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1832
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares